Postepy W Kardiologii Interwencyjnej最新文献

{"title":"Percutaneous left atrial appendage closure with the Watchman device: a systematic review.","authors":"Jakub Maksym, Marcin Grabowski, Tomasz Mazurek","doi":"10.5114/aic.2024.136406","DOIUrl":"https://doi.org/10.5114/aic.2024.136406","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is the most commonly observed arrhythmia in the world and its prevalence increases with age. The main and most severe complication of AF is ischemic stroke. Oral anticoagulation (OAC) therapy is the standard of care for stroke prevention in the high risk population. Initiation of this treatment is associated with a substantial risk of bleeding complications. Moreover, there is a group of patients who cannot tolerate OAC. In patients with AF the left atrial appendage (LAA) is the main source of thrombus formation. Percutaneous left atrial appendage closure (LAAC) has become an important non-pharmacological intervention for stroke prevention in patients with non-valvular AF. The procedure aims to reduce the risk of thromboembolism without increasing the risk of bleeding. Over the last few years, the safety and long-term efficacy of the procedure in specific populations have increased and more patients are being treated. The Watchman device is the most studied device in this field. Randomized controlled trials demonstrated non-inferiority of percutaneous left atrial appendage closure using the WATCHMAN 2.5 device to OAC (Boston Scientific, Marlborough, MA, USA). The new generation device, WATCHMAN FLX, was introduced and its use was associated with fewer safety events and a higher success rate of effective appendage closure. Nevertheless, several unsolved problems remain, including device-related thrombosis, the post-LAAC antithrombotic regimen, and peri-device leakage. This review will focus on LAAC with the Watchman device for stroke prevention in AF patients. Current status, available literature, clinical safety and efficacy will be summarized.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"20 1","pages":"18-29"},"PeriodicalIF":1.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Machine learning models using symptoms and clinical variables to predict coronary artery disease on coronary angiography.","authors":"Yangjie Yu, Weikai Li, Jiajia Wu, Xuyun Hua, Bo Jin, Haiming Shi, Qiying Chen, Junjie Pan","doi":"10.5114/aic.2024.136416","DOIUrl":"https://doi.org/10.5114/aic.2024.136416","url":null,"abstract":"<p><strong>Introduction: </strong>Coronary angiography (CAG) is invasive and expensive, while numbers of patients suspected of coronary artery disease (CAD) undergoing CAG results have no coronary lesions.</p><p><strong>Aim: </strong>To develop machine learning algorithms using symptoms and clinical variables to predict CAD.</p><p><strong>Material and methods: </strong>This study was conducted as a cross-sectional study of patients undergoing CAG. We randomly chose 2082 patients from 2602 patients suspected of CAD as the training set, and 520 patients as the test set. We utilized LASSO regression to do feature selection. The area under the receiver operating characteristic curve (AUC), confusion matrix of different thresholds, positive predictive value (PPV) and negative predictive value (NPV) were shown. Support vector machine algorithm performances in 10 folds were conducted in the training set for detecting severe CAD, while XGBoost algorithm performances were conducted in the test set for detecting severe CAD.</p><p><strong>Results: </strong>The algorithm of logistic regression achieved an average AUC of 0.77 in the training set during 10-fold validation and an AUC of 0.75 in the test set. When probability predicted by the model was less than 0.1, 11 patients in the test set (520 patients) were screened out, and NPV reached 90.9%. When probability predicted by the model was less than 0.2, 110 patients in the test set were screened out, and reached 83.6%. Meanwhile, when threshold was set to 0.9, PPV reached 97.4%. When the threshold was set to 0.8, PPV reached 91.5%.</p><p><strong>Conclusions: </strong>Machine learning algorithm using data from hospital information systems could assist in severe CAD exclusion and confirmation, and thus help patients avoid unnecessary CAG.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"20 1","pages":"30-36"},"PeriodicalIF":1.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multiple thrombotic coronary occlusions after acute traumatic subarachnoid hemorrhage.","authors":"Nart Zafer Baytuğan, Hasan Çağlayan Kandemir","doi":"10.5114/aic.2024.136902","DOIUrl":"https://doi.org/10.5114/aic.2024.136902","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"20 1","pages":"115-116"},"PeriodicalIF":1.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008516/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension - reference center experience.","authors":"Andrzej Łabyk, Marcin Krakowian, Łukasz Mysiorski, Barbara Lichodziejewska, Olga Dzikowska-Diduch, Aisha Ou-Pokrzewińska, Dariusz Zieliński, Marek Gołębiowski, Piotr Pruszczyk, Marek Roik","doi":"10.5114/aic.2024.136411","DOIUrl":"https://doi.org/10.5114/aic.2024.136411","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic thromboembolic pulmonary hypertension (CTEPH), characterized by thromboembolic changes affecting the pulmonary bed, leads to ventricular function deterioration and premature death. The introduction of balloon pulmonary angioplasty (BPA) has significantly improved the prognosis of CTEPH patients.</p><p><strong>Aim: </strong>The authors of this article decided to summarize the experience of the BPA program, conducted between 2014 and 2022, at the reference center.</p><p><strong>Material and methods: </strong>Among 111 CTEPH patients, 55 were included in the analysis. A total of 226 sessions were performed, with a significant percentage of intravascular imaging and pressure catheter use.</p><p><strong>Results: </strong>Mean pulmonary pressure decreased significantly from 42 (22-66) to 26.5 mm Hg (11-54) (<i>p</i> < 0.05). Pulmonary vascular resistance and natriuretic peptide concentration decreased from 6.67 (1.66-14) to 3.295 Wood units (1.09-11.11), respectively, and from 1934 (60-16963) to 296 (21-9901) ng/ml (<i>p</i> < 0.05). There was also an improvement in the functional class (WHO) from 2.85 ±0.61 to 2.15 ±0.62 and an increase in the 6-minute walking distance from 300 ±131 to 367 ±154 m (<i>p</i> < 0.05). There were no in-hospital deaths or within 30 days of the procedure. Arterial damage occurred during nine sessions (<i>n</i> = 9/226, 4%), while 0.9% (<i>n</i> = 2/226) were complicated by acute right ventricular failure. Post-reperfusion pulmonary edema (RPE 0 - none) was observed in almost 90% of the sessions, grade 1 to 3 RPE occurred in 10.2%, and grade 4 RPE was not noted.</p><p><strong>Conclusions: </strong>BPA programs conducted in experienced centers are a safe and effective treatment option for inoperable CTEPH patients.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"20 1","pages":"84-88"},"PeriodicalIF":1.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of external iliac artery diameter indexed to BSA score in predicting vascular access complications after transfemoral transcatheter aortic valve implantation.","authors":"Monika Gruz-Kwapisz, Tomasz Gasior, Adrianna Hajder, Wojciech Wanha, Joanna Ciosek, Andrzej Ochala, Radosław Parma, Radoslaw Gocol, Wojciech Wojakowski, Damian Hudziak","doi":"10.5114/aic.2024.136407","DOIUrl":"https://doi.org/10.5114/aic.2024.136407","url":null,"abstract":"<p><strong>Introduction: </strong>Aortic stenosis is the most common primary valve disease and requires invasive treatment. Transcatheter aortic valve implantation (TAVI) from a transfemoral access is a routine intervention worldwide.</p><p><strong>Aim: </strong>To investigate the correlation between external iliac artery diameter (EIAD) indexed to body surface area (BSA) (EIAD-BSA) and access site complications in patients undergoing TAVI via transfemoral access (TF) (TF-TAVI).</p><p><strong>Material and methods: </strong>Patients underwent TF-TAVI in 2017-2019 at the Upper-Silesian Medical Center in Katowice. Based on the preoperative multi-slice computed tomography (MSCT), pre-specified measurements of the ilio-femoral vessels were performed. The results were indexed to BSA and body mass index (BMI). Complications after TAVI were defined by Valve Academic Research Consortium 3 (VARC-3). The primary outcome regarding the adverse events after TAVI was the composite of access site complications requiring surgical intervention or blood transfusion.</p><p><strong>Results: </strong>The registry included 193 unselected patients with severe symptomatic aortic stenosis. Vascular and access-related complications including bleeding occurred in 17.1% of patients. Major TAVI access site complications (VARC-3) were reported in 5.7% of patients, while minor complications (VARC-3) occurred in 2.6%. EIAD-BSA demonstrated a positive correlation with the access site complications primary endpoint. Patients with greater EIAD-BSA had a numerically higher number of access site adverse events requiring surgical intervention or blood transfusion: <i>n</i> = 12 (5%) vs. <i>n</i> = 4 (4%), <i>p</i> = 0.011.</p><p><strong>Conclusions: </strong>External iliac artery diameter indexed to BSA could be an underestimated indicator of unfavorable outcomes after TF-TAVI, predicting periprocedural access site complications.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"20 1","pages":"76-83"},"PeriodicalIF":1.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Microvascular spasm: between <i>experientia</i> and <i>evidentia</i>.","authors":"Aleksandra Gąsecka, Łukasz Kołtowski","doi":"10.5114/aic.2023.133813","DOIUrl":"10.5114/aic.2023.133813","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"19 4","pages":"388-389"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rectus sheath hematoma after percutaneous coronary intervention and hemodialysis.","authors":"Nart Zafer Baytuğan, Hasan Çağlayan Kandemir","doi":"10.5114/aic.2023.133812","DOIUrl":"10.5114/aic.2023.133812","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"19 4","pages":"382-383"},"PeriodicalIF":1.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139379136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The change of angina levels in patients with chronic coronary syndromes and coronary microcirculatory dysfunction - a prospective study with 24 months follow-up.","authors":"Łukasz Niewiara, Paweł Kleczyński, Piotr Szolc, Bartłomiej Guzik, Marta Diachyshyn, Michalina Jelonek, Joanna Handzlik, Krzysztof Żmudka, Jacek Legutko","doi":"10.5114/aic.2023.133806","DOIUrl":"10.5114/aic.2023.133806","url":null,"abstract":"<p><strong>Introduction: </strong>A substantial proportion of patients with chronic coronary syndromes suffer from angina even after medical treatment and revascularization. Coronary microvascular dysfunction (CMD) is discussed as a potential mechanism.</p><p><strong>Aim: </strong>To assess angina status in patients with chronic coronary syndromes undergoing functional assessment of coronary circulation regarding the presence of coronary microcirculatory dysfunction.</p><p><strong>Material and methods: </strong>The study included 101 consecutive patients referred for coronary angiography requiring functional stenosis assessment, with median age of 66 years, 74% male, diagnosed or treated for dyslipidemia (91%) and diabetes type 2 (42%), 20% with a history of prior non-ST myocardial infarction. Fractional flow reserve (FFR), coronary flow reserve (CFR), resistive reserve ratio (RRR), and index of microcirculatory resistance (IMR) were measured. The diagnosis of CMD was defined by either IMR ≥ 25 units or CFR ≤ 2.0 in case of no significant stenosis. A change of one CCS class over 24 months follow-up was considered clinically significant.</p><p><strong>Results: </strong>In patients without CMD diagnosis, there was a significant decrease in angina intensity (<i>p</i> < 0.001). Lack of angina improvement was associated with lower median RRR (2.30 (1.70, 3.30) vs. 3.05 (2.08, 4.10), <i>p</i> = 0.004) and lower median CFR (1.90 (1.40, 2.50) vs. 2.30 (IQR: 1.60, 3.00), <i>p</i> = 0.021), as compared to patients with angina improvement.</p><p><strong>Conclusions: </strong>The presence of CMD is a risk factor for no angina improvement. Impaired coronary resistive reserve ratio and lower microvascular reactivity may be one of the pathomechanisms leading to the lack of angina improvement in patients with chronic coronary syndromes.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"19 4","pages":"318-325"},"PeriodicalIF":1.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous treatment of native aortic coarctation performed in infants and children up to ten years old: a single-center experience.","authors":"Natalia Kowalska, Paweł Dryżek, Anna Mazurek-Kula, Hanna Ditrych, Tomasz Moszura, Sebastian Góreczny","doi":"10.5114/aic.2023.133226","DOIUrl":"10.5114/aic.2023.133226","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"19 4","pages":"375-377"},"PeriodicalIF":1.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139379134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of outcomes in patients with severe aortic stenosis treated with small and large Medtronic Evolut R and Evolut PRO self-expandable prosthetic valves.","authors":"Krzysztof Wilczek, Piotr Chodór, Jan Harpula, Tomasz Hrapkowicz, Łukasz Włoch, Karolina Chodór-Rozwadowska, Grzegorz Honisz, Mariusz Gąsior, Zbigniew Kalarus","doi":"10.5114/aic.2023.133810","DOIUrl":"10.5114/aic.2023.133810","url":null,"abstract":"<p><strong>Introduction: </strong>Indications for transcatheter aortic valve implantation (TAVI) continue to expand. Very often TAVI must be done in large annuli. Implantation of the bigger prostheses is often associated with more procedural problems, which may affect the outcomes.</p><p><strong>Aim: </strong>To compare the outcomes of TAVI procedures using the self-expandable Medtronic Evolut R 34 with the smaller Evolut R or Evolut Pro 23, 26 or 29.</p><p><strong>Material and methods: </strong>We analysed 87 patients who received self-expandable Medtronic Evolut R and Pro valves. Group I consisted of 59 (67.81%) patients with Evolut 23, 26 or 29, and group II consisted of 28 (32.18%) patients who received an Evolut 34 valve.</p><p><strong>Results: </strong>EuroSCORE II was 5.59 in group I vs 7.87 in group II (<i>p</i> = 0.02). The oversizing rate was higher in group II: 24.1% vs. 18.5% (<i>p</i> < 0.001). The procedure and fluoroscopy times were longer in group II: 209 vs. 187 min (<i>p</i> = 0.03), 44 vs. 27 min (<i>p</i> = 0.01). Moderate paravalvular leak was found more frequently in group II: 5 v 1 (<i>p</i> = 0.04). There was less device success in group II: 22 (78.57%) vs. 57 (96.6%) (<i>p</i> = 0.05). Early safety criteria were similar in both groups: 52 (88.1%) and 24 (92.3%) (<i>p</i> = 0.56). 30-day mortality was similar: 4 (6.7%) vs. 0 in group I and II respectively (<i>p</i> = 0.16).</p><p><strong>Conclusions: </strong>TAVI procedures in patients requiring an Evolut R 34 prosthesis are more challenging than in those who need smaller valves. Paravalvular leaks are more frequently observed after TAVI with Evolut R 34, which results in lower device success.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"19 4","pages":"359-366"},"PeriodicalIF":1.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10767566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}